Effects of probenecid and brilliant blue G on rat enteric glial cells following intestinal ischemia and reperfusion.

Autor: Mendes CE; Department of Anatomy, University of São Paulo, Brazil., Palombit K; Department of Morphology, University Federal of Piaui, Brazil., Alves Pereira TT; Department of Anatomy, University of São Paulo, Brazil., Riceti Magalhães HI; Department of Surgery, School of Veterinary Medicine and Animal Sciences, University of São Paulo, Brazil., Ferreira Caetano MA; Department of Anatomy, University of São Paulo, Brazil., Castelucci P; Department of Anatomy, University of São Paulo, Brazil. Electronic address: pcastel@usp.br.
Jazyk: angličtina
Zdroj: Acta histochemica [Acta Histochem] 2023 Jan; Vol. 125 (1), pp. 151985. Date of Electronic Publication: 2022 Dec 07.
DOI: 10.1016/j.acthis.2022.151985
Abstrakt: The P2X7 receptor participates in several intracellular events and acts with the pannexin-1 channel. This study examined the effects of probenecid (PB) and brilliant blue G (BBG), which are antagonists of the pannexin-1 channel and P2X7 receptor, respectively, on rat ileum enteric glial cells after on ischemia and reperfusion. The ileal vessels were occluded for 45 min with nontraumatic vascular tweezers, and reperfusion was performed for periods of 24 h and 14 and 28 days. After ischemia (IR groups), the animals were treated with BBG (BG group) or PB (PB group). The double-labeling results demonstrated the following: the P2X7 receptor was present in enteric glial cells (S100β) and enteric neurons positive for HuC/D; enteric glial cells exhibited different phenotypes; some enteric glial cells were immunoreactive to only S100β or GFAP; and the pannexin-1 channel was present in enteric glial cells (GFAP). Density (in cells/cm 2 ) analyses showed that the IR group exhibited a decrease in the number of cells immunoreactive for the P2X7 receptor, pannexin-1, and HuC/D and that treatment with BBG or PB resulted in the recovery of the numbers of these cells. The number of glial cells (S100β and GFAP) was higher in the IR group, and the treatments decreased the number of these cells to the normal value. However, the PB group did not exhibit recovery of S100β-positive glia. The cell profile area (μm 2 ) of S100β-positive enteric glial cells decreased to the normal value after BBG treatment, whereas no recovery was observed in the PB group. The ileum contractile activity was decreased in the IR group and returned to baseline in the BG and PB groups. BBG and PB can effectively induce the recovery of neurons and glia cells and are thus potential therapeutic agents in the treatment of gastrointestinal tract diseases.
Competing Interests: Conflicts of Interest The authors declare no conflicts of interest.
(Copyright © 2022 Elsevier GmbH. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: